(1 - 14 von 19
)
Philogen Enters into Multi-Target Research Agreement with Boehringer...
www.eleconomista.es
Darryl McConnell, Vice President and Head, Boehringer Ingelheim Research Site Austria, said, “We are very excited about the opportunity to apply ...
Boehringer Ingelheim and Vanderbilt University expand partnership to...
news.vumc.org
... proteins KRAS, SOS and now, MCL1,” said Darryl McConnell, Ph.D., Vice President and Research Site Head, Boehringer Ingelheim, Austria.
Patients, Advocates, Researchers Come Together to Kick Cancer's ...www.finanzen.net › Aktien
www.finanzen.net
· Darryl McConnell, Ph.D., Senior Vice President and Research Site Head at Boehringer-Ingelheim Regional Centre Vienna, Austria, ...
Partnership extended to develop novel anti-cancer drugs targeting...
... MCL1,” said Darryl McConnell, PhD, vice president and research site head, Boehringer Ingelheim, Austria. “Together, we are committed to ...
sortiert nach Relevanz / Datum